{"entity":{"type":"insider","cik":"0001492646","url":"/insider/0001492646","json_url":"/insider/0001492646.json","name":"McIntyre Gail Frances","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":7,"first":"2011-11-21","last":"2021-06-29","span_basis":"filed_date"},"name_variants":[{"name":"McIntyre Gail Frances","source":"filing","n_filings":7,"first_seen":"2011-11-21","last_seen":"2021-06-29"}],"transactions":[{"id":5388852,"accession":"0001437749-21-015969","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-21-015969","line_url":"/filing/0001437749-21-015969#line-1","is_derivative":false,"issuer_cik":"0001492646","issuer_name":"Aravive, Inc.","issuer_ticker":"ARAV","issuer_name_source":null,"issuer_url":"/issuer/0001492646","owner_cik":"0001492646","owner_name":"McIntyre Gail Frances","owner_display_name":"McIntyre Gail Frances","owner_url":"/insider/0001492646","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":5.345,"price_display":"5.34","price_state":"stated","total_value":5345.0,"total_display":"5,345.00","total_whole":"5,345","shares_owned_after":11137.0,"shares_owned_after_display":"11,137","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-29","filed_date":"2021-06-29","scope":"insider"},{"id":2169949,"accession":"0000899243-20-032918","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-032918","line_url":"/filing/0000899243-20-032918#line-1","is_derivative":false,"issuer_cik":"0001492646","issuer_name":"Aravive, Inc.","issuer_ticker":"ARAV","issuer_name_source":null,"issuer_url":"/issuer/0001492646","owner_cik":"0001492646","owner_name":"McIntyre Gail Frances","owner_display_name":"McIntyre Gail Frances","owner_url":"/insider/0001492646","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":5.77,"price_display":"5.77","price_state":"stated","total_value":46160.0,"total_display":"46,160.00","total_whole":"46,160","shares_owned_after":10137.0,"shares_owned_after_display":"10,137","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-04","filed_date":"2020-12-07","scope":"insider"},{"id":6801023,"accession":"0001437749-14-011463","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001437749-14-011463","line_url":"/filing/0001437749-14-011463#line-9","is_derivative":false,"issuer_cik":"0001484478","issuer_name":"Furiex Pharmaceuticals, Inc.","issuer_ticker":"FURX","issuer_name_source":null,"issuer_url":"/issuer/0001484478","owner_cik":"0001492646","owner_name":"McIntyre Gail Frances","owner_display_name":"McIntyre Gail Frances","owner_url":"/insider/0001492646","role":"Officer (Senior Vice President-Research)","role_mark":"O","role_mark_label":"Officer (Senior Vice President-Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President-Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8008.0,"shares_display":"8,008","price_per_share":105.0,"price_display":"105.00","price_state":"stated","total_value":840840.0,"total_display":"840,840.00","total_whole":"840,840","shares_owned_after":24318.0,"shares_owned_after_display":"24,318","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-17","filed_date":"2014-06-18","scope":"insider"},{"id":6801017,"accession":"0001437749-14-011463","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001437749-14-011463","line_url":"/filing/0001437749-14-011463","is_derivative":false,"issuer_cik":"0001484478","issuer_name":"Furiex Pharmaceuticals, Inc.","issuer_ticker":"FURX","issuer_name_source":null,"issuer_url":"/issuer/0001484478","owner_cik":"0001492646","owner_name":"McIntyre Gail Frances","owner_display_name":"McIntyre Gail Frances","owner_url":"/insider/0001492646","role":"Officer (Senior Vice President-Research)","role_mark":"O","role_mark_label":"Officer (Senior Vice President-Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President-Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":66449.0,"shares_display":"66,449","price_per_share":105.0067096570302,"price_display":"105.01","price_state":"stated","total_value":6977590.85,"total_display":"6,977,590.85","total_whole":"6,977,591","shares_owned_after":24318.0,"shares_owned_after_display":"24,318","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-16","filed_date":"2014-06-18","scope":"insider","n_lines":4},{"id":6996465,"accession":"0001437749-14-011097","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-14-011097","line_url":"/filing/0001437749-14-011097#line-1","is_derivative":false,"issuer_cik":"0001484478","issuer_name":"Furiex Pharmaceuticals, Inc.","issuer_ticker":"FURX","issuer_name_source":null,"issuer_url":"/issuer/0001484478","owner_cik":"0001492646","owner_name":"McIntyre Gail Frances","owner_display_name":"McIntyre Gail Frances","owner_url":"/insider/0001492646","role":"Officer (Senior Vice President-Research)","role_mark":"O","role_mark_label":"Officer (Senior Vice President-Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President-Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1746.0,"shares_display":"1,746","price_per_share":104.58,"price_display":"104.58","price_state":"stated","total_value":182596.68,"total_display":"182,596.68","total_whole":"182,597","shares_owned_after":28122.0,"shares_owned_after_display":"28,122","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-10","filed_date":"2014-06-12","scope":"insider"},{"id":9287873,"accession":"0001437749-13-012117","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-13-012117","line_url":"/filing/0001437749-13-012117#line-1","is_derivative":false,"issuer_cik":"0001484478","issuer_name":"Furiex Pharmaceuticals, Inc.","issuer_ticker":"FURX","issuer_name_source":null,"issuer_url":"/issuer/0001484478","owner_cik":"0001492646","owner_name":"McIntyre Gail Frances","owner_display_name":"McIntyre Gail Frances","owner_url":"/insider/0001492646","role":"Officer (Senior Vice President-Research)","role_mark":"O","role_mark_label":"Officer (Senior Vice President-Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President-Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":800000.0,"total_display":"800,000.00","total_whole":"800,000","shares_owned_after":17868.0,"shares_owned_after_display":"17,868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-19","filed_date":"2013-09-18","scope":"insider"},{"id":5547041,"accession":"0001437749-13-009182","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001437749-13-009182","line_url":"/filing/0001437749-13-009182#line-3","is_derivative":false,"issuer_cik":"0001484478","issuer_name":"Furiex Pharmaceuticals, Inc.","issuer_ticker":"FURX","issuer_name_source":null,"issuer_url":"/issuer/0001484478","owner_cik":"0001492646","owner_name":"McIntyre Gail Frances","owner_display_name":"McIntyre Gail Frances","owner_url":"/insider/0001492646","role":"Officer (Senior Vice President-Research)","role_mark":"O","role_mark_label":"Officer (Senior Vice President-Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President-Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10581.0,"shares_display":"10,581","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":423240.0,"total_display":"423,240.00","total_whole":"423,240","shares_owned_after":17868.0,"shares_owned_after_display":"17,868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-19","filed_date":"2013-07-23","scope":"insider"},{"id":9132163,"accession":"0001181431-11-057117","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-057117","line_url":"/filing/0001181431-11-057117#line-1","is_derivative":false,"issuer_cik":"0001484478","issuer_name":"Furiex Pharmaceuticals, Inc.","issuer_ticker":"FURX","issuer_name_source":null,"issuer_url":"/issuer/0001484478","owner_cik":"0001492646","owner_name":"McIntyre Gail Frances","owner_display_name":"McIntyre Gail Frances","owner_url":"/insider/0001492646","role":"Officer (Senior Vice President-Research)","role_mark":"O","role_mark_label":"Officer (Senior Vice President-Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President-Research","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6500.0,"shares_display":"6,500","price_per_share":16.89,"price_display":"16.89","price_state":"stated","total_value":109785.0,"total_display":"109,785.00","total_whole":"109,785","shares_owned_after":6768.0,"shares_owned_after_display":"6,768","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-17","filed_date":"2011-11-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001513818","name":"Aravive, Inc.","url":"/issuer/0001513818","role":"Director, Officer (CEO and President)","n_filings":2,"first_seen":"2020-12-07","last_seen":"2021-06-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001484478","name":"Furiex Pharmaceuticals, Inc.","url":"/issuer/0001484478","role":"Officer (Senior Vice President-Research)","n_filings":5,"first_seen":"2011-11-21","last_seen":"2014-06-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001492646","retrieved_at":"2026-08-25T08:08:04+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}